Fig. 3.
EMP2 suppresses tumor formation.
EMP2 was recombinantly reintroduced into MV cells using a pSRα retroviral expression vector. Balb/c mice were injected intraperitoneally with 5 × 105 vector control or mEMP2 overexpressing cells. Mice were monitored for up to 50 days for tumor formation.
